TOMI's SteraMist iHP Proves Effective Against Listeria Biofilm in Independent Lab Tests

  • Independent lab results show SteraMist iHP reduced Listeria monocytogenes biofilm by >7 log on flat surfaces and >3 log on hard-to-reach equipment parts.
  • TOMI partnered with Josh Hasty, Ph.D., CEO of FH Services, to bring the data to food industry customers.
  • The global food sanitation market is projected to grow from $9.9 billion in 2026 to $17.4 billion by 2035, with North America as the largest region at $3.67 billion in 2025.

TOMI's successful lab results position it to capitalize on the growing demand for advanced food sanitation technologies, particularly in the North American market. The partnership with Dr. Hasty underscores TOMI's strategic focus on the food processing sector, where Listeria contamination remains a persistent challenge. The projected market growth highlights the significant opportunity for TOMI to expand its customer base and revenue streams in this high-need industry.

Market Penetration
How TOMI will leverage Dr. Hasty's industry connections to convert lab results into customer evaluations and sales.
Competitive Positioning
Whether TOMI can sustain its growth in the food safety sector against established competitors.
Regulatory Compliance
The pace at which food safety regulations may evolve to favor or require advanced disinfection technologies like SteraMist iHP.